wereenrolledintheU.S.,India,Lithuania,PhilippinesandColumbia,the geographicregionsubgroupanalysesshowedrobustresultsfavoringlurasidone overplaceboconsistentlyintheColombiaregionandnottheotherregions. TheDivisionofScientificInvestigationsdidnotfindanysignificantissueswith anyoftheclinicalsitesthatwereinspected,noFormFDA483swere...